Drug wholesale prices up over 7% in 2007

Pharmaceutical manufacturers increased wholesale prices for the 50 top-selling branded medications by an average of 7.82% in 2007, after increases of 6.73% and 6.22% in the previous two years, according to data from marketing research firm Delta Marketing Dynamics.

The most recent increase is almost double the overall U.S. economy's 4.1% annual inflation rate last year, a report in today's Wall Street Journal said.

GlaxoSmithKline raised the price of its antidepressant Wellbutrin XL by 44.5% from 2005 to 2007. Sanofi Aventis raised the price of its sleep drug Ambien 70.1%.

Shire upped the price of its attention-deficit disorder treatement, Adderall XR, by 33.5%.

Pfizer's cholesterol-fighting Lipitor -- the world's top-selling Rx drug with $13 billion in sales, rose 16%.

You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.